The aging process: Where are the drug opportunities?

Current Opinion in Chemical Biology

Volumn 4, Issue 4, 2000, Pages 371-376

  Smith, Roy G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA ADRENERGIC RECEPTOR; BETA SECRETASE; CELL NUCLEUS RECEPTOR; ENZYME INHIBITOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA SECRETASE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HEXARELIN; HORMONE RECEPTOR STIMULATING AGENT; IBUTAMOREN; MONOAMINE OXIDASE B INHIBITOR; PRESENILIN 1; PRESENILIN 2; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

AGING; ALZHEIMER DISEASE; BONE TURNOVER; CLINICAL TRIAL; DOPAMINERGIC NERVE CELL; DRUG BINDING; DRUG BINDING SITE; DRUG SELECTIVITY; DRUG TARGETING; DRUG TOLERABILITY; GROWTH HORMONE RELEASE; HEART PROTECTION; HOT FLUSH; HUMAN; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; POSTMENOPAUSE; REVIEW; SENILE PLAQUE;

EID: 0033862370     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00104-6     Document Type: Review

References (50)

1. Human growth hormone-research and clinical practice
2. Therapeutic controversy - Treatment of growth hormone deficiency in adults
3. Peptidomimetic regulation of growth hormone (GH) secretion
4. A new orphan receptor involved in pulsatile growth hormone release
5. A receptor in pituitary and hypothalamus that functions in growth hormone release
6. Ligand activation domain of human orphan growth hormone secretagogue receptor (GHS-R) conserved from pufferfish to humans
7. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
8. Stimulation of the growth hormone (GH)-insulin-like growth factor-I axis by daily oral administration of a GH secretagogue (MK-0677) in healthy elderly subjects
9. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man
10. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency
11. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient adults
12. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 study group
13. Hexarelin, a growth hormone - Releasing peptide, counteracts bone loss in gonadectomized male rats
14. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency
15. Effect of recombinant human growth hormone in elderly osteoporotic women
16. Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency
17. Impaired cardiac performance in elderly patients with growth hormone deficiency
18. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction
19. Growth hormone-independent cardioprotective effects of hexarelin in the rat
20. Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aorticrings of the hypophysectomized rat
21. Cardiac effects of hexarelin in hypopituitary adults
22. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart
23. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
24. Identification of a novel aspartic protease (Asp 2) as beta-secretase
25. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
26. Cellular mechanisms of beta-amyloid production and secretion
27. Purification and cloning of amyloid precursor protein beta-secretase from human brain
28. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein
29. The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation
30. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
31. Neuroendocrine influences and repercussions of the menopause
32. Alternatives to the use of estrogen in postmenopausal women
33. Estrogen actions in the central nervous system
34. Estrogen is more than just a 'sex hormone': Novel sites for estrogen action in the hippocampus and cerebral cortex
35. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats
36. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system
37. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice
38. A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain
39. 4.5 kb of the rat tyrosine hydroxylase 5' flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors
40. Characterization of the 5'-flanking region of the human dopamine transporter gene
41. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes
42. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice
43. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury
44. Nuclear receptor coregulators: Cellular and molecular biology
45. Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2
46. Lack of protection of monoamine oxidase B-deficient mice from age-related spatial learning deficits in the Morris water maze
47. 1-Deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons
48. Symptomatic and neuroprotective properties of the aliphatic propargylamines
49. Neuroprotection by (-)-deprenyl and related compounds
50. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues